JENKINTOWN, Pa., November 26, 2007 — The National Comprehensive Cancer Network (NCCN) announces important updates to the NCCN Pancreatic Adenocarcinoma Guidelines. The NCCN Clinical Practice Guidelines in Oncology™ are widely recognized and applied as the standard of care in oncology in the United States in both the community and the academic practice settings.
These NCCN Guidelines feature a new section covering principles of palliation and supportive care. This is an especially important addition since a significant subset of patients with advanced pancreatic cancer will require substantial palliative interventions, including management of symptoms due to biliary obstruction, gastric outlet obstruction and severe tumor-associated abdominal pain.
In addition, greater emphasis has been placed on the use of neoadjuvant therapy in patients with borderline resectable pancreatic adenocarcinoma. The new version of the guidelines contains a separate decision pathway to provide more specific guidance when neoadjuvant therapy is planned for patients with borderline resectable disease. This pathway includes a clarifying, corresponding footnote stating that “The majority of NCCN institutions prefer upfront neoadjuvant therapy in the setting of borderline resectable disease.”
NCCN Clinical Practice Guidelines in Oncology™ are developed and updated through an evidence-based process with explicit review of the scientific evidence by multidisciplinary panels of expert physicians from NCCN Member Institutions. The most recent version of this and all the guidelines are available free of charge at www.nccn.org.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved